Characterization of porcine partially reprogrammed iPSCs from adipose-derived stem cells

Reproduction

Volumn 149, Issue 5, 2015, Pages 485-496

  Wei, Chao ^a   Li, Xia ^a   Zhang, Pengfei ^a   Zhang, Yu ^a   Liu, Tong ^a   Jiang, Shaoshuai ^a   Han, Fei ^a   Zhang, Yunhai ^a  

^a ANHUI AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; DNA METHYLTRANSFERASE 3B; ENDOGLIN; FIZZY RELATED PROTEIN; GALECTIN 1; HERMES ANTIGEN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MYC PROTEIN; NESTIN; NEUROGENIC DIFFERENTIATION FACTOR; NEUTROPHIL COLLAGENASE; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX9;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BLASTOCYST; BONE DEVELOPMENT; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; DNA CONTENT; EMBRYO; EXPERIMENTAL PIG; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CYTOLOGY; EMBRYOID BODY; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEK293 CELL LINE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; PHYSIOLOGY; PIG; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSGENIC ANIMAL; WESTERN BLOTTING;

ANIMALIA; MUS; SUS;

ADIPOSE TISSUE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; EMBRYOID BODIES; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED ICR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; SWINE;

EID: 84929149488     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-14-0410     Document Type: Article

References (56)

1. Bar-Nur O, Russ HA, Efrat S & Benvenisty N 2011 Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet b cells. Cell Stem Cell 9 17-23. (doi:10.1016/j.stem.2011.06.007)
2. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA et al. 2009 Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnology 27 1033-1037. (doi:10.1038/nbt.1580)
3. Chang DD, Wong C, Smith H & Liu J 1997 ICAP-1, a novel β1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of β1 integrin. Journal of Cell Biology 138 1149-1157. (doi:10.1083/jcb.138.5.1149)
4. Cho KS & Roh HJ 2010 Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Current Stem Cell Research & Therapy 5 111-115. (doi:10.2174/157488810791268681)
5. 2. Tissue Engineering 13 1185-1195. (doi:10.1089/ten.2006.0315)
6. Darabi R, Gehlbach K, Bachoo RM, Kamath S, Osawa M, Kamm KE, Kyba M & Perlingeiro RC 2008 Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nature Medicine 14 134-143. (doi:10.1038/nm1705)
7. Deng W, Yang D, Zhao B, Ouyang Z, Song J, Fan N, Liu Z, Zhao Y, Wu Q, Nashun B et al. 2011 Use of the 2A peptide for generation of multitransgenic pigs through a single round of nuclear transfer. PLoS ONE 6 13. (doi:10.1371/annotation/22351496-73dc-4205-9d9a-95a821ae74ca)
8. Fan N, Chen J, Shang Z, Dou H, Ji G, Zou Q, Wu L, He L, Wang F, Liu K et al. 2013 Piglets cloned from induced pluripotent stem cells. Cell Research 23 162-166. (doi:10.1038/cr.2012.176)
9. Feng B, Ng JH, Heng JC & Ng HH 2009 Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4 301-312. (doi:10.1016/j.stem.2009.03.005)
10. Gieseke F, Bohringer J, Bussolari R, Dominici M, Handgretinger R &Muller I 2010 Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116 3770-3779. (doi:10.1182/blood-2010-02-270777)
11. Gropp M, Itsykson P, Singer O, Ben-Hur T, Reinhartz E, Galun E &Reubinoff BE 2003 Stable genetic modification of human embryonic stem cells by lentiviral vectors. Molecular Therapy 7 281-287. (doi:10.1016/S1525-0016(02)00047-3)
12. Groth A, Ottinger S, Kleist C, Mohr E, Golriz M, Schultze D, Bruns H, Mehrabi A, Schemmer P, Buchler MW et al. 2012 Evaluation of porcine mesenchymal stem cells for therapeutic use in human liver cancer. International Journal of Oncology 40 391-401. (doi:10.3892/ijo.2011.1217)
13. Hu Q, Friedrich AM, Johnson LV & Clegg DO 2010 Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 28 1981-1991. (doi:10.1002/stem.531)
14. Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q & Zhao RC 2012 Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells and Development 21 2531-2540. (doi:10.1089/scd.2012.0014)
15. Ichim TE, Harman RJ, Min WP, Minev B, Solano F, Rodriguez JP, Alexandrescu DT, De Necochea-Campion R, Hu XA, Marleau AM et al. 2010 Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cellular Immunology 264 7-17. (doi:10.1016/j.cellimm.2010.04.002)
16. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, Ludlow JW, Stricker DM, Potiny S, Green P et al. 2007 Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, pro-inflammatory factors. Journal of Cellular Physiology 212 702-709. (doi:10.1002/jcp.21068)
17. Kim S, Chang KA, Kim J, Park HG, Ra JC, Kim HS & Suh YH 2012 The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer's disease mice. PLoS ONE 7 e45757. (doi:10.1371/journal.pone.0045757)
18. Koivisto H, Hyvarinen M, Stromberg AM, Inzunza J, Matilainen E, Mikkola M, Hovatta O & Teerijoki H 2004 Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reproductive Biomedicine Online 9 330-337. (doi:10.1016/S1472-6483(10)62150-5)
19. Lamfers M, Idema S, van Milligen F, Schouten T, van der Valk P, Vandertop P, Dirven C & Noske D 2009 Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Cancer Letters 274 78-87. (doi:10.1016/j.canlet.2008.08.035)
20. Lee JM, Jung J, Lee HJ, Jeong SJ, Cho KJ, Hwang SG & Kim GJ 2012 Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. International Immunopharmacology 13 219-224. (doi:10.1016/j.intimp.2012.03.024)
21. Lindroos B, Suuronen R & Miettinen S 2011 The potential of adipose stem cells in regenerative medicine. Stem Cell Reviews 7 269-291. (doi:10.1007/s12015-010-9193-7)
22. Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Stewart AF, Smith A et al. 2012 The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149 590-604. (doi:10.1016/j.cell.2012.03.026)
23. Martin MJ, Muotri A, Gage F & Varki A 2005 Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nature Medicine 11 228-232. (doi:10.1038/nm1181)
24. Matsui T, Takano M, Yoshida K, Ono S, Fujisaki C, Matsuzaki Y, Toyama Y, Nakamura M, Okano H & Akamatsu W 2012 Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency. Stem Cells 30 1109-1119. (doi:10.1002/stem.1091)
25. Mattout A, Biran A & Meshorer E 2011 Global epigenetic changes during somatic cell reprogramming to iPS cells. Journal of Molecular Cell Biology 3 341-350. (doi:10.1093/jmcb/mjr028)
26. Mikkelsen TS, Hanna J, Zhang XL, Ku MC, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES & Meissner A 2008 Dissecting direct reprogramming through integrative genomic analysis (vol 454, pg 49, 2008). Nature 454 794-794. (doi:10.1038/nature07196)
27. Nguyen BK, Maltais S, Perrault LP, Tanguay JF, Tardif JC, Stevens LM, Borie M, Harel F, Mansour S & Noiseux N 2010 Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. Journal of Cardiovascular Translational Research 3 547-558. (doi:10.1007/s12265-010-9171-0)
28. Nichols J & Smith A 2009 Naive and primed pluripotent states. Cell Stem Cell 4 487-492. (doi:10.1016/j.stem.2009.05.015)
29. Okita K, Ichisaka T & Yamanaka S 2007 Generation of germline-competent induced pluripotent stem cells. Nature 448 313-317. (doi:10.1038/nature05934)
30. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M & Werner C 2004 Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22 377-384. (doi:10.1634/stemcells.22-3-377)
31. Pan G & Pei D 2012 Order from chaos: single cell reprogramming in two phases. Cell Stem Cell 11 445-447. (doi:10.1016/j.stem.2012.09.004)
32. Park IH, Zhao R, West JA, Yabuuchi A, Huo HG, Ince TA, Lerou PH, Lensch MW & Daley GQ 2008 Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 141-146. (doi:10.1038/nature06534)
33. Plath K & Lowry WE 2011 Progress in understanding reprogramming to the induced pluripotent state. Nature Reviews. Genetics 12 253-265. (doi:10.1038/nrg2955)
34. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T et al. 2010 Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology 28 848-855. (doi:10.1038/nbt.1667)
35. Rafei M, Hsieh J, Fortier S, Li M, Yuan S, Birman E, Forner K, Boivin MN, Doody K, Tremblay M et al. 2008 Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood 112 4991-4998. (doi:10.1182/blood-2008-07-166892)
36. Rege TA & Hagood JS 2006 Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB Journal 20 1045-1054. (doi:10.1096/fj.05-5460rev)
37. Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne JY, Wdziekonski B, Villageois A, Bagnis C, Breittmayer JP, Groux H et al. 2005 Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. Journal of Experimental Medicine 201 1397-1405. (doi:10.1084/jem.20042224)
38. Rodriguez A, Allegrucci C & Alberio R 2012 Modulation of pluripotency in the porcine embryo and iPS cells. PLoS ONE 7 e49079. (doi:10.1371/journal.pone.0049079)
39. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP &Wohlgemuth R 2008 Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nature Medicine 14 181-187. (doi:10.1038/nm1703)
40. Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM & Rice HE 2002 Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochemical and Biophysical Research Communications 294 371-379. (doi:10.1016/S0006-291X(02)00469-2)
41. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW & Smith A 2008 Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biology 6 e253. (doi:10.1371/journal.pbio.0060253)
42. Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I & Smith A 2009 Nanog is the gateway to the pluripotent ground state. Cell 138 722-737. (doi:10.1016/j.cell.2009.07.039)
43. 2. Blood 113 6576-6583. (doi:10.1182/blood-2009-02-203943)
44. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, Zhou Q & Plath K 2009 Role of the murine reprogramming factors in the induction of pluripotency. Cell 136 364-377. (doi:10.1016/j.cell.2009.01.001)
45. Stadtfeld M & Hochedlinger K 2010 Induced pluripotency: history, mechanisms, and applications. Genes and Development 24 2239-2263. (doi:10.1101/gad.1963910)
46. Sullivan GJ, Bai Y, Fletcher J & Wilmut I 2010 Induced pluripotent stem cells: epigenetic memories and practical implications. Molecular Human Reproduction 16 880-885. (doi:10.1093/molehr/gaq091)
47. Takahashi K & Yamanaka S 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 663-676. (doi:10.1016/j.cell.2006.07.024)
48. Tobita M, Orbay H & Mizuno H 2011 Adipose-derived stem cells: current findings and future perspectives. Discovery Medicine 11 160-170.
49. Trivedi HL, Vanikar AV, Thakker U, Firoze A, Dave SD, Patel CN, Patel JV, Bhargava AB & Shankar V 2008 Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplantation Proceedings 40 1135-1139. (doi:10.1016/j.transproceed.2008.03.113)
50. Wei C, Liu X, Tao J, Wu R, Zhang P, Bian Y, Li Y, Fang F & Zhang Y 2013 Effects of vitamin C on characteristics retaining of in vitro-cultured mouse adipose-derived stem cells. In Vitro Cellular & Developmental Biology. Animal 50 75-86. (doi:10.1007/s11626-013-9673-6)
51. West FD, Uhl EW, Liu Y, Stowe H, Lu Y, Yu P, Gallegos-Cardenas A, Pratt SL & Stice SL 2011 Brief report: chimeric pigs produced from induced pluripotent stem cells demonstrate germline transmission and no evidence of tumor formation in young pigs. Stem Cells 29 1640-1643. (doi:10.1002/stem.713)
52. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M &Bueren JA 2006 Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24 2582-2591. (doi:10.1634/stemcells.2006-0228)
53. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917-1920. (doi:10.1126/science.1151526)
54. Zhang Y, Wei C, Zhang P, Li X, Liu T, Pu Y, Li Y, Cao Z, Cao H, Liu Y et al. 2014 Efficient reprogramming of naive-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system. PLoS ONE 9 e85089. (doi:10.1371/journal.pone.0085089)
55. Zhou N, Cao Z, Wu R, Liu X, Tao J, Chen Z, Song D, Han F, Li Y, Fang F et al. 2014 Dynamic changes of histone H3 lysine 27 acetylation in pre-implantational pig embryos derived from somatic cell nuclear transfer. Animal Reproduction Science 148 153-163. (doi:10.1016/j.anireprosci.2014.06.002)
56. Zhu W, Shi XL, Xiao JQ, Gu GX, Ding YT & Ma ZL 2013 Effects of xenogeneic adipose-derived stem cell transplantation on acute-on-chronic liver failure. Hepatobiliary & Pancreatic Diseases International 12 60-67. (doi:10.1016/S1499-3872(13)60007-7)